Macquarie Group LTD Teva Pharmaceutical Industries LTD Transaction History

Macquarie Group LTD

$90.3 Billion
Q3 2024

A detailed history of Macquarie Group LTD transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Macquarie Group LTD holds 45,664 shares of TEVA stock, worth $989,995. This represents 0.0% of its overall portfolio holdings.

Number of Shares

45,664

Previous 43,334 5.38%

Holding current value

$989,995

Previous $704,000 16.76%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$15.81 - $18.96 $36,837 - $44,176	2,330 Added 5.38%	45,664 $822,000
Q2 2024 Aug 09, 2024	SELL	$12.78 - $17.4 $9,469 - $12,893	-741 Reduced 1.68%	43,334 $704,000
Q1 2024 May 14, 2024	BUY	$10.67 - $14.43 $106,081 - $143,463	9,942 Added 29.13%	44,075 $621,000
Q4 2023 Feb 14, 2024	BUY	$8.12 - $10.63 $6,382 - $8,355	786 Added 2.36%	34,133 $356,000
Q3 2023 Nov 14, 2023	SELL	$7.48 - $10.7 $34,378 - $49,177	-4,596 Reduced 12.11%	33,347 $340,000
Q2 2023 Aug 14, 2023	SELL	$7.2 - $9.47 $37,418 - $49,215	-5,197 Reduced 12.05%	37,943 $285,000
Q4 2022 Feb 21, 2023	BUY	$7.95 - $9.48 $51,539 - $61,458	6,483 Added 17.69%	43,140 $393,000
Q3 2022 Nov 14, 2022	SELL	$6.86 - $11.95 $1,440 - $2,509	-210 Reduced 0.57%	36,657 $296,000
Q2 2022 Aug 15, 2022	SELL	$7.38 - $10.4 $60,833 - $85,727	-8,243 Reduced 18.27%	36,867 $278,000
Q4 2021 Feb 11, 2022	SELL	$7.9 - $10.19 $440,504 - $568,194	-55,760 Reduced 55.28%	45,110 $361,000
Q3 2021 Nov 12, 2021	BUY	$8.38 - $10.18 $74,406 - $90,388	8,879 Added 9.65%	100,870 $982,000
Q2 2021 Aug 13, 2021	SELL	$9.9 - $11.56 $153,083 - $178,752	-15,463 Reduced 14.39%	91,991 $910,000
Q4 2020 Feb 16, 2021	SELL	$8.61 - $11.04 $4.32 Million - $5.54 Million	-501,700 Reduced 82.36%	107,454 $1.04 Million
Q3 2020 Nov 13, 2020	BUY	$8.57 - $12.69 $426,151 - $631,022	49,726 Added 8.89%	609,154 $5.49 Million
Q2 2020 Aug 11, 2020	SELL	$8.12 - $13.12 $11.9 Million - $19.2 Million	-1,463,872 Reduced 72.35%	559,428 $6.9 Million
Q4 2019 Feb 14, 2020	BUY	$6.53 - $10.72 $107,092 - $175,808	16,400 Added 0.82%	2,023,300 $19.8 Million
Q2 2019 Aug 14, 2019	BUY	$8.12 - $15.72 $4.3 Million - $8.33 Million	530,000 Added 35.89%	2,006,900 $18.5 Million
Q1 2019 May 15, 2019	BUY	$15.58 - $20.01 $22.5 Million - $28.9 Million	1,445,400 Added 4588.57%	1,476,900 $23.2 Million
Q4 2018 Feb 15, 2019	SELL	$14.59 - $23.84 $10,213 - $16,688	-700 Reduced 2.17%	31,500 $485,000
Q3 2018 Nov 15, 2018	SELL	$21.06 - $25.65 $2.16 Million - $2.63 Million	-102,700 Reduced 76.13%	32,200 $693,000
Q2 2018 Aug 14, 2018	SELL	$16.77 - $24.71 $385,710 - $568,330	-23,000 Reduced 14.57%	134,900 $3.28 Million
Q1 2018 May 11, 2018	SELL	$16.68 - $22.07 $80,064 - $105,936	-4,800 Reduced 2.95%	157,900 $2.7 Million
Q4 2017 Feb 15, 2018	SELL	$11.23 - $19.1 $47.7 Million - $81.1 Million	-4,245,631 Reduced 96.31%	162,700 $3.68 Million
Q3 2017 Nov 08, 2017	BUY	$15.41 - $32.17 $67.9 Million - $142 Million	4,408,331	4,408,331 $77.6 Million

Others Institutions Holding TEVA

# of Institutions

629

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $24.1B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Teva Pharmaceutical Industries LTD Transaction History